Further investigation revealed that there is a complex interplay between the impaired PPARα signaling observed in AD patients that contributes to GLT-1 loss in the hippocampus and cerebral cortex and the overall disease progression [69]. Here, SLC1A2 is linked to Alzheimer disease.